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Abstract Experimental mild heat shock is widely
known as an intervention that results in extended lon-
gevity in various models along the evolutionary lineage.
Heat shock proteins (HSPs) are highly upregulated
immediately after a heat shock. The elevation in HSP
levels was shown to inhibit stress-mediated cell death,
and recent experiments indicate a highly versatile role
for these proteins as inhibitors of programmed cell
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death. In this study, we examined common genetic
variations in 31 genes encoding all members of the
HSP70, small HSP, and heat shock factor (HSF) families
for their association with all-cause mortality. Our dis-
covery cohort was the Rotterdam study (RS1) contain-
ing 5,974 participants aged 55 years and older (3,174
deaths). We assessed 4,430 single nucleotide polymor-
phisms (SNPs) using the HumanHap550K Genotyping
BeadChip from Illumina. After adjusting for multiple
testing by permutation analysis, three SNPs showed
evidence for association with all-cause mortality in
RS1. These findings were followed in eight independent
population-based cohorts, leading to a total of 25,007
participants (8,444 deaths). In the replication phase,
only HSF2 (rs1416733) remained significantly associ-
ated with all-cause mortality. Rs1416733 is a known cis-
eQTL forHSF2. Our findings suggest a role ofHSF2 in
all-cause mortality.
Keywords Heat shock proteins . HEATshock factor
2 . All-cause mortality
Introduction
Experimental mild heat shock is widely known as an
intervention that results in extended longevity (Cypser
and Johnson 2001). Brief exposure to elevated heat
resulted in a 15 % increase in the mean life span of
Caenorhabditis elegans, compared to non heat-shocked
controls (Cypser and Johnson 2001; Cypser and Johnson
2002; Lithgow et al. 1995). Similar effects have also
been seen in Drosophila melanogaster (Hercus et al.
2003; Le Bourg et al. 2001), in yeast (Shama et al.
1998), and in cultured human cells (Rattan 1998). In
the early 1960s, a group of proteins, now known as heat
shock proteins (HSPs) were discovered, which were
highly upregulated immediately after a heat shock
(Ritossa 1962, 1996). Whether HSPs are responsible
for longevity is still under debate, as their levels are only
elevated for a short period of time after a heat shock
(Link et al. 1999). However, the elevation in HSP levels
during the heat shock response was shown to inhibit
stress-mediated cell death, and recent experiments
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indicate a highly versatile role for these proteins as inhib-
itors of programmed cell death (Garrido et al. 2006).
HSPs can be subdivided in several smaller families,
including HSP90, HSP70, HSP60, HSP40, small HSP
(sHSP), and HSP10 (Kampinga et al. 2009). From these
families, HSP70 and sHSPs show an association with
longevity. In C. elegans, extra copies of a homolog of
HSPA9 (member of HSP70), otherwise known as mor-
talin, extended life span up to 45 % (Yokoyama et al.
2002). In humans, decreased serum levels of HSP70
have been associated with exceptional longevity (95+)
(Terry et al. 2006). However, the same study evaluated
two single nucleotide polymorphisms (SNPs) in
HSPA1A and HSPA1B which were not found to be
associated to exceptional longevity (Terry et al. 2006).
The over-expression of members of the sHSP fam-
ily has been shown to extend life of C. elegans and D.
melanogaster by up to 32 % (Morrow et al. 2004b;
Walker et al. 2001). Conversely, the absence of ex-
pression of a sHSP member decreases lifespan of D.
melanogaster by 40 % (Morrow et al. 2004a).
HSP expression is regulated by a group of tran-
scription factors known as heat shock factors (HSFs),
of which HSF1 is considered to be the master-switch
of HSP expression (Akerfelt et al. 2010). Strong
evidence exists for a highly important role for HSF1
in longevity. Reduced activity of HSF1 in C. elegans
leads to a rapid aging phenotype with a markedly
reduced lifespan of 60 % (Garigan et al. 2002). Con-
versely, animals with an additional HSF1 gene copy
lived approximately 40 % longer than normal (Hsu et
al. 2003). A strong relationship was found between
HSF1 and DAF-16, which functions in the C. elegans
insulin/IGF-1 signaling pathway (Hsu et al. 2003).
Both genes were shown to function, at least in part,
by increasing sHSP gene expression (Hsu et al. 2003).
We have tested 31 genes encoding all members of
the HSP70, sHSP, and HSF families and assessed their
association with all-cause mortality. To our knowl-
edge, this is the first large-scale candidate gene study
of these HSPs and their association to all-cause mor-
tality to be performed.
Methods
Discovery study
Our discovery cohort was the Rotterdam study (RS1).
RS1 is a population-based cohort study that investigates
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the occurrence and determinants of diseases in the el-
derly (Hofman et al. 2011). Baseline examinations, in-
cluding a detailed questionnaire, physical examination,
and blood collection, were conducted between 1990 and
1993. The Medical Ethics Committee at Erasmus Med-
ical Center approved the study protocol. All of the
participants were followed for incident diseases through
linkage to the general practitioner data base and
record review by trained medical investigators. Gen-
eral practitioners' hospital records as well as death
certificates were used for identification of deaths (all-
cause mortality) through January 1, 2009.
Genomic DNA was extracted from whole blood
samples using standard methods (Miller et al. 1988).
Genome-wide SNP genotyping was performed using
Infinium II assay on the HumanHap550 Genotyping
BeadChips (Illumina Inc, San Diego, USA). Approx-
imately two million SNPs were imputed using release
22 HapMap CEU population as reference. The impu-
tations were performed using MACH software (http://
www.sph.umich.edu/csg/abecasis/MACH/). The qual-
ity of imputations were checked by contrasting imputed
and actual genotypes at 78,844 SNPs not present on
Illumina 550K for 437 individuals for whom these SNPs
were directly typed using Affymetrix 500K. Using the
“best guess” genotype for imputed SNPs the concor-
dance rate was 99 % for SNPs with R2 (ratio of the
variance of imputed genotypes to the binomial variance)
quality measure greater than 0.9; concordance was still
over 90 % (94 %) when R2 was between 0.5 and 0.9.
The GWAS of all-cause mortality has been analyzed and
is published elsewhere (Walter et al. 2011).
For the study of HSPs presented here, a total of
4,430 SNPs in 31 genes were initially selected for the
association test on the basis of the following criteria:
(1) position within the genes of interest with a margin
of 100 kb on each side of the genes according to NCBI
build 36.3; (2) p value for Hardy–Weinberg equilibrium
test ≥0.0001; and (3) call rate ≥95 %. For further anal-
ysis and selection of SNPs for replication analysis, only
SNPs with an R2 higher than 0.8 and a minor allele
frequency higher than 0.05 were selected.
Analyses
We performed single SNP analyses using ProbABEL
(Aulchenko et al. 2010). We used survival analysis
(semi-parametric Cox proportional hazard model), ad-
justed for age at DNA blood collection and for sex, to
model continuous time to death in individuals that
were older than 55 years at baseline. To calculate
empirical significance for SNPs, permutations were
performed per region of interest (ROI) (Churchill and
Doerge 1994; Fisher 1935). Briefly, the empirical dis-
tribution of the region-wide maximum of the test
statistic under the null was obtained in 10,000 repli-
cations. To estimate empirical significance, each ob-
served test statistic was compared with null statistics
obtained empirically and the p value was estimated as
the proportion of replicas generating the test statistics
greater than or equal to the observed statistic. The
permutation analysis keeps the original genotypes for
each individual, but randomly allocates the pheno-
types for each consecutive permutation. Therefore,
the linkage disequilibrium structure of genes is not
broken up. We did not perform any additional correc-
tion for the number of ROIs after permutations as we
used the permutation analysis to significantly reduce
the number of SNPs to be selected for validation of the
effect of the SNP. For each suggestively associated ROI
(ppermuted < 0.10), we next selected the “truly associated”
SNPs in a backward stepwise survival analysis until
only nominally significant SNPs remained in the model.
These independently associated SNPs were then fol-
lowed up in eight independent cohorts. As effect esti-
mates are expected to be small, a strict replication based
on the p value and hazard ratio (HR) observed in indi-
vidual replication studies, might be difficult to achieve
due to power issues. Therefore, we evaluated whether a
SNP was showing a HR in the same direction in all
cohorts, i.e., whether findings were consistent over the
various cohorts. Similar to genome-wide association
studies, we performed a joint meta-analysis of the dis-
covery and the replication samples and tested whether
the joint p value was significant using a Bonferroni
correction for the number of SNPs validated in the
replication phase.
We used four studies that are part of the Cohorts for
Heart and Aging Research in Genomic Epidemiology
(CHARGE) consortium (Psaty et al. 2009) plus an
additional four associated cohorts to evaluate whether
findings were consistent. The studies included in this
replication are: Cardiovascular Health Study (CHS);
Framingham Heart Study (FHS); Atherosclerosis Risk
Communities Study (ARIC); Age, Gene/Environment
Susceptibility–Reykjavik Study (AGES); Health, Ag-
ing and Body Composition (HABC); Baltimore Lon-
gitudinal Study of Ageing (BLSA); InCHIANTI
1370 AGE (2013) 35:1367–1376
(ICH); and Study of Health in Pomerania (SHIP). All
studies are longitudinal population-based studies peri-
odically assessing the health and vital status of their
participants. All participants included in this analysis
were at least 55 years of age at the time of blood draw
for DNA and provided written informed consent. De-
tailed information on the replication studies can be
found in the supplement.
Results
General characteristics of the discovery cohort as well
as the eight replication cohorts are shown in Table 1.
In the discovery cohort, there were 3,174 deaths with a
mean age at death of 83.2 and mean follow-up of
12.5 years. In RS1 and replications combined, there
were 8,444 deaths with a mean age at death of 81.1.
The mean follow-up time ranged from 5.2 to
15.7 years. A summary of all SNPs tested in the
HSP genes in RS1 can be found in Supplementary
Table 1. Three HSP70 genes are located head to head
on chromosome 6 and are taken as one ROI with 148
SNPs (HSPA1). Similarly, two sHSP genes on chro-
mosome 11 with 66 SNPs were located nearby each
other and taken as one ROI (ROIchr11). Also of note
is that the HSPs are currently undergoing a change in
nomenclature (Kampinga et al. 2009). Supplementary
Table 1 provides both the official gene names and
the gene names according to the new nomencla-
ture. Here, we will use the aliases from the new
nomenclature.
Figure 1 a–d illustrate the observed versus the
expected chi2 of the SNPs tested in the different HSP
gene families in RS1. The plots show an excess of low
p values for tested SNPs in sHSP (1b) and HSF (1c)
but not for HSP70 (1a). Supplementary Fig. 1 shows
an overview of the p values in all HSP70, sHSP, and
HSF genes tested in RS1. After adjusting for multiple
testing by permutation analysis, three genes showed
evidence for association to mortality in RS1. These
genes encode HSP70 member HSPA8, sHSP member
HSPB1, and HSF member HSF2. Table 2 shows the
three SNPs that were selected for replication. In the
replication phase, only one SNP reached a Bonferroni
adjusted p value for significance (0.05/300.017).
Figure 2a shows the Forest plot of the meta-analysis
of HSF2 rs1416733. The direction of effect was consis-
tent across populations with only one study (HABC)
showing an opposite HR. The summary HR for this
SNP was 0.95 (95 % CI 0.92–0.98; p00.003) for the
A allele. When excluding the discovery cohort from the
meta-analysis, the HR remained virtually unchanged
(0.97: CI 0.93–1.00). In Fig. 2b, a regional plot of all
SNPs tested in HSF2 from the original RS1 cohort can
be found. In the plot, we can see that rs1416733 is
located 11.7 Kb from the 5′ region of the HSF2 gene,
with no other genes nearby.
Table 1 General characteristics
Study N N deceased Mean age at
Baseline (±SD)
Mean age at
death (±SD)
Sex, %
female
Mean follow-up
time in years (±SD)
Rotterdam study (RS1) 5974 3,174 69.4 (9.1) 83.2 (8.3) 59 12.5 (5.2)
Cardiovascular health study (CHS) 3,267 1,718 72.3 (5.4) 83.4 (6.3) 61 12.3 (4.2)
Framingham heart study (FHS) 3,136 654 70.0 (10.2) 83.0 (9.3) 56 6.0 (2.4)
Atherosclerosis risk communities
study (ARIC)
4,511 1,108 59.4 (2.9) 71.3 (5.4) 50 15.7 (3.7)
Age, gene/environment susceptibility-
Reykjavik study (AGES)
3,219 558 76.4 (5.5) 79.3 (5.9) 58 5.2 (1.3)
The health, aging and body
composition (HABC)
1,661 460 73.8 (2.8) 80.4 (3.7) 47 8.2 (2.3)
Baltimore longitudinal study
of ageing (BLSA)
620 183 62.0 (8.8) 86.8 (8.0) 41 15.7 (8.2)
Invecchiare nel Chianti (InCHIANTI) 902 183 72.5 (7.7) 85.4 (7.9) 56 5.9 (0.9)
Study of health in Pomerania (SHIP) 1,717 406 66.4 (7.2) 76.9 (7.2) 47 9.2 (2.4)
TOTAL 25,007 8,444 69.0 (8.9) 81.1 (8.4) 55 10.6 (5.4)
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Fig. 1 Observed versus expected p value plot for the SNPs
tested in the Rotterdam study (chi2 are given at the x-axis and
y-axis). a HSP70; b sHSP; c HSF. Black line depicts the
expected findings; red line depicts the observed ones T
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Discussion
In our study, we found a significant association between
HSF2 and all-cause mortality. The top associated vari-
ant, rs1416733, is located 11.7 Kb from the 5′ region of
the HSF2 gene on chromosome 6 and is a known cis-
eQTL for HSF2 (Zeller et al. 2010). Each additional
copy of the A allele for SNP rs1416733 increased life-
span with a HR of 0.95 in a meta-analysis of nine
independent cohort studies. This effect was consistent
in direction in eight out of nine cohorts.
The HSF family, like most HSP families, is a highly
conserved family across species, indicating a vital role
for the survival of the respective organism (Liu et al.
1997). Unlike many other HSP families, there is vir-
tually no redundancy in the HSF family, with HSF1 as
the most crucial family member (Akerfelt et al. 2010).
The importance of HSF1 is advocated strongly by the
large effects of genetic mutations in this gene on
longevity in C. elegans (Garigan et al. 2002; Hsu et
al. 2003). These large effects are not anticipated in
human research, which could explain why we find no
A. Forrest plot 
B. Regional plot in RS1 
Fig. 2 The meta-analysis of
the HSF2 rs1416733 SNP
in the nine population
cohorts. a Forrest plot.
b Regional plot in RS1
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evidence for association of SNPs in HSF1 with all-
cause mortality (Walter et al. 2011). HSF2 is less
known in longevity research. It has previously been
mainly described for its role as a development- and
differentiation-specific factor (Kallio et al. 2002;
Wang et al. 2003). The role of HSF2 in later life has
remained unknown for a long time (Wu 1995). Re-
cently, evidence is emerging to suggest that HSF2
modulates HSF1 activity (Akerfelt et al. 2010). It has
been shown that HSF2 activation leads to activation of
HSF1, revealing a functional interdependency
(Sandqvist et al. 2009). It has been proposed that
heterotrimerization of HSF1 and HSF2 integrates tran-
scriptional activation in response to distinct stress and
developmental stimuli (Sandqvist et al. 2009). Addi-
tionally, though HSF2 was never considered to be
heat-inducible, a recent study shows that a mild heat-
shock in the physiological range does activate HSF2
and has a significant impact on the proteostasis of the
cell (Shinkawa et al. 2011).
We found no evidence for association of HSP70 with
all-cause mortality. HSP70 is the only HSP family for
which SNPs in a couple of genes have been studied for
longevity in humans previously. However, these studies
only studied two or three SNPs and only in the heat-
inducible members of HSP70, namely HSPA1A,
HSPA1B, and HSPA1L, all located on chromosome 6
(Altomare et al. 2003; Ross et al. 2003; Terry et al.
2006). In our study, no association was found for these
three genes with longevity. We add a more thorough
investigation of these genes and the other HSP70 genes
by extensively covering common variance.
The sHSPs have been named most often in animal
studies for their relationship with longevity (Morrow
et al. 2004a; Morrow et al. 2004b; Walker et al. 2001).
However, we find no significant associations for sin-
gle SNPs in these genes. Off course, what we find in
animal studies does not always translate well to
humans. For example, though genetic variations in
IGF-1 signaling have been found in humans, they do
not have nearly as strong effects on longevity as in
animal models (Kuningas et al. 2008). Another study
has found that mutations in HSF1 lead to upregulated
sHSP expression in C. elegans (Hsu et al. 2003). We
cannot exclude that genetic variation in HSF2 acti-
vates a similar mechanism in humans through its effect
on HSF1.
Our study has a major advantage since the discovery
cohort—the Rotterdam Study—is a large, population-
based study. Further, the eight replication cohorts are
also relatively large, established population-based epi-
demiological cohorts. A limitation in the interpretation
of our data is that our findings were significant in the
meta-analysis but did not reach significance in the indi-
vidual cohorts except for the RS1 cohort; however, a
total of eight out of nine studies showed an effect in the
same direction forHSF2. This could be explained by the
markedly smaller percentage of deaths in most replica-
tion cohorts (except CHS) compared to the discovery
cohort. The number of deceased is critical for the statis-
tical power of the study. Even though some of these
studies had a longer mean follow-up time (ARIC and
BLSA), the population in these studies were on average
younger at baseline compared to RS1, which explains
the fewer number of deaths and leaves the individual
replication studies underpowered to identify rs1416733.
Until now, no large-scale studies have been per-
formed investigating the role of HSP70, sHSP, or
HSF genes in all-cause mortality in humans. In our
candidate gene study in nine population-based
cohorts, we found significant evidence suggesting that
genetic variants in HSF2 are associated with all-cause
mortality. Combining these data with those of earlier
functional studies, in particular in C. elegans, makes it
likely that HSF2 plays a role in human all-cause
mortality.
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